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Abstract
Moyamoya is a rare chronic progressive occlusive cerebrovascular disease. Its 
manifestation varies from stroke, progressive learning impairment and transient 
ischemic attack to headache and seizure. There is no accepted medical treatment 
and surgery usually, is needed. We report here a case of 8 yr old boy referred 
to psychiatrist outpatient. An eight yr old boy with intermittent hemiplegia 
was brought to Imam Ali Clinic, Yazd, Iran in 2015 because his headache and 
medical problem began from 6 yr old. Stress and excitement exacerbated his 
condition. His first attack was at the age of 6 yr old. During attack, he had 
incontinence, severe headache, alogia, pallor, claudication and left hemiplegia 
(Left lower limb). Magnetic resonance angiography (MRA) was done and our 
diagnosis was moyamoya disease. Moyamoya is a mysterious disease and 
psychiatrists should consider it in differential diagnosis of alogia and plegia. 
Acute management of this disease is mainly symptomatic. Nowadays, surgery 
is a good choice and early diagnosis of this disease can change our patient’s 
life.
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Introduction 
Moyamoya disease (MMD) is multifocal occlusive arterial disease (distal), 
hereditary and linked to chromosome 17 (1). Moyamoya is a Japanese expression for 
something hazy like cigarette smoke and its incidence is higher in Japan (2). MMD 
occurs mostly in children in Asia. It is a rare cerebrovascular disease. The annual 
rate of newly diagnosed cases of MMD in 1994 was 0.35 per 100000 associated 
with 6% of childhood acute strokes. Spontaneous occlusion of circle of Willis 
usually happens in this disease (3, 4). In China the prevalence is 3.92/100 000 (5).
Although often reports about MMD are related eastern countries like Japan, but it 
is probably in other countries and we intend to report a case of 8 yr old boy referred 
to our clinic.
Case report
An Iranian 8 yr old boy was brought to Imam Ali Clinic, Yazd, Iran in 2015. The 
low socio economic area in north of Yazd this clinic is a special clinic related to 
Shahid Sadoughi university of medical sciences, Yazd, Iran because of intermittent 
hemiplegia and headache. His medical problem began from 6 yr old. As mother’s 
history, stress and excitement exacerbate his condition. His past medical history 
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Fig 1. Stenosis of supraclinoid internal carotid vasculature with a proliferation 
of collateral vessels (Puffs of smoke appearance) 
he experienced an episode. During attack he had 
incontinence, severe headache, alogia, pallor, 
claudication and left hemiplegia (Left lower limb). He 
had not vomited and visual disturbances. The child had 
so much stress about his attack and was conscious on his 
disease. 
Paraclinical Findings
Magnetic Resonance angiography findings:
The marked stenosis of supraclinoid internal carotid 
vasculature with a proliferation of collateral vessels 
(Puffs of smoke appearance) suggestive MMD were 
noted (Figure 1, 2).
was clear except a head trauma following falling at the 
age of 2 yr old and he had no hemorrhagic events, loss 
of consciousness or fracture after head truma. His birth 
weight was 3140 gr and now was 19 kg. He was lower 
than normal limit in spite of normal diet, probably due to 
disease. Her parents had not consanguinity of marriage. 
He had no congenital anomaly, language problem or 
developmental delay or learning disorder. Informed 
Consent was taken from his mother.
IQ test was normal and he was a good student without 
academic problem. His mother did not mention 
childbirth complication but she experienced noticeable 
stress during pregnancy. 
The first attack was started in 6 yr-old following 
an emotional condition. Nearly every two weeks, 
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Fig 2. Stenosis of supraclinoid internal carotid vasculature with a proliferation of collateral vessels (Puffs of smoke 
appearance) 
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we can see hypodensity small areas but MRA should 
be performed for the clear-cut diagnosis, follow-up and 
detect of acute infarcts regions (10, 11). Because of the 
noninvasive nature of MRI, MRA is primary diagnostic 
imaging modality for MMD (12). Earlier diagnosis may 
prevent additional neurologic deficits.
Currently, there is no accepted medical treatment for 
reversing of this progressive disease and management 
mainly is symptomatic. Some patients stabilize 
clinically without intervention, but this condition 
usually occurs after they have experienced neurologic 
disability. However, there are some evidence for the use 
of anticoagulants/antiplatelet agents and vasodilators. 
Aspirin is a suitable choice (80 mg daily those younger 
than 6 yr). The calcium channel blockers are the other 
medication class. These drugs may be effective in 
reducing symptoms (like headache) or in reducing both 
the frequency and severity of refractory TIA (11).
The literature supports of revascularization procedures 
through surgery and surgery can reduce cerebral 
ischemic events especially in patients with recurrent 
or progressive course Non-surgically treated MMD 
prognosis is not clear yet (13). 
In this case, patient responds to sodium valproate. It can 
cause thrombocytopenia and can help blood circulation. 
Besides, it can help to relieve tension and anxiety and 
then reduce vasoconstriction (14).
As we know, MMD has a progressive nature. We do 
surgical treatment to prevent ischemia or infarction. 
In addition, antiplatelet treatment has used in treating 
in MMD but we do not have enough evidence base 
medicine in this case (15).
In Conclusion, the physician should know Moyamoya 
and its neurologic presentations in childhood. Physicians 
should consider it in differential diagnosis of seizure, 
headache, plus plegia and treat resistant cases to medical 
treatment in children.
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Treatment
His response to tablet sodium valproate (200 mg 
daily) was better than nortriptyline 25 mg at night and 
lamotrigine 25 mg/daily. 
Follow-up
We visited him every 2 months. Following prescription 
of sodium valproate, he had one attack only, although 
we suggested for consultation with a neurosurgeon.
Discussion
MMD is a chronic cerebrovascular disease and often 
presents with hemorrhage or transient ischemic attack, 
leading to cerebral stroke. 
The most common differential diagnosis of this condition 
is seizures and strokes. Some diseases have relative 
association with this disease (Patients with structural 
congenital heart disease). Conversion disorder is the 
other differential diagnosis (6). The investigations were 
negative for conversion disorder and malingering and he 
had no primary or secondary gain or attention sicking.
Age is one of the most important factors. Symptomatic 
presentation of MMD depends on it and is related to 
prognosis. Nearly half of the patients observed from 
1961 to 1980 were children below 15 yr (7). The 
symptoms were varied from no symptoms to transient 
or even fixed disease but transient ischemic attack was 
predominated in children. Adults usually present with 
intracranial hemorrhage (ICH), and this can lead to 
paralysis and severe headache.
TIA can manifest as episodes of hemiparesis, speech 
and visual disturbance, sensory impairment and we 
must consider MMD especially when the symptoms are 
related to emotional states, cry or physical activity (8).
Yamauchi et al. reported familial occurrence of MMD as 
5%-15% (9). Actually, mother-to-child inheritance was 
observed in a few cases (about 5 cases of 68 patients) 
and father-to-child inheritance was so rare (9). Our case 
had no positive familial history.
The diagnosis of MMD is confirmed by radiographic 
studies such as CT scan and MRI as well as MRI 
angiography. The characteristic findings are arterial 
narrowing (puff of smoke, a commonly low-density 
area in the white matter of the temporal lobe) and clear 
collaterals. The workup begins with brain CT scan and 
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